RESOLUCION_C-1082-19.pdf
37.17 KB
IP_Web_C-1082-19_BAVARIAN-ACTIVOS_GSK_DEF.pdf
72.71 KB
Competencia
Adquisición control exclusivo
12 des. 2019
Adquirente
BAVARIAN NORDIC, A/S
Adquirida
GLAXOSMITHKLINE BIOLOGICALS, S.A.
GSK VACCINES GMBH